MP488DAILY EXIT-SITE AND INTRANASAL MUPIROCIN IN ALL PD PATIENTS TO PREVENT STAPHYLOCOCCUS AUREUS PERITONITIS: A MORE EFFECTIVE APPROACH THAN MONTHLY INTRANASAL MUPIROCIN IN STAPHYLOCOCCUS AUREUS CARRIERS ONLY
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.